Skip to main content
. Author manuscript; available in PMC: 2023 Apr 15.
Published in final edited form as: Eur J Med Chem. 2022 Mar 11;234:114272. doi: 10.1016/j.ejmech.2022.114272

Table 4.

Validation of docking setup for HDAC10-inhibitor complexes from the Protein DataBank

PDB ID Cocryst. ligand Enzyme (Resolution) RMSD (Å) of top ranked pose Best RMSD (Å) among top-5 ranked poses Best RMSD (Å) and docking rank
5TD7 7-[(3-aminopropyl)amino]-1,1,1-trifluoroheptane-2,2-diol drHDAC10 (2.65 Å) 1.91 1.78 0.89 (119)
6UFN 7-[(3-aminopropyl)amino]heptan-2-one drHDAC10 (2.70 Å) 1.22 0.84 0.66 (292)
6UFO 7-[(3-aminopropyl)amino]-1-methoxyheptan-2-one drHDAC10 (2.68 Å) 1.08 1.07 0.51 (283)
6UHV 6-[(3-aminopropyl)amino]-N-hydroxyhexanamide drHDAC10 (2.53 Å) 1.25 1.15 0.75 (110)
6UHU 5-[(3-aminopropyl)amino]pentyl boronic acid drHDAC10 (2.80 Å) 1.60 1.45 0.72 (166)
6UII 5-[(3-aminopropyl)amino]pentane-1-thiol drHDAC10 (2.65 Å) 0.81 0.59 0.59 (3)
6UIJ S-{5-[(3-aminopropyl)amino]pentyl} thioacetate drHDAC10 (2.90 Å) 1.06 1.05 0.51 (117)
6UIL 7-[(3-aminopropyl)amino]-1,1,1-trifluoroheptan-2-one drHDAC10 (2.85 Å) 0.79 0.78 0.57 (216)
6UIM 7-{[(3-aminopropyl)amino]-2-oxoheptyl} thioacetate drHDAC10 (2.75 Å) 2.93 1.31 0.69 (62)
6VNQ bishydroxamate humanized drHDAc10 (2.05 Å) 0.35 0.35 0.32 (16)
6WBQ hydroxamate humanized drHDAc10 (2.00 Å) 0.54 0.54 0.54 (1)
6WDV hydroxamate humanized drHDAc10 (2.40 Å) 0.53 0.53 0.47 (26)
6WDW hydroxamate humanized drHDAc10 (2.20 Å) 0.35 0.39 0.34 (59)
6WDX hydroxamate humanized drHDAc10 (2.65 Å) 0.62 0.52 0.36 (30)
6WDY hydroxamate humanized drHDAc10 (2.65 Å) 0.62 0.58 0.52 (6)
7KUQ acetyl-spermidine drHDAC10 Y307F mutant (2.10 Å) 1.16 0.44 0.24 (55)
7KUR acetyl-putrescine drHDAC10 Y307F mutant (2.10 Å) 0.73 0.73 0.18 (64)
7KUS acetyl-spermidine drHDAC10 H137A mutant (2.00 Å) 1.09 1.09 0.62 (128)
7KUT acetyl-putrescine drHDAC10 H137A mutant (2.05 Å) 0.69 0.64 0.25 (97)